Financial reports
ARS
2023 FY
Annual report to shareholders
22 Apr 24
10-K
2023 FY
Annual report
7 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
24 Apr 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
Current reports
8-K
ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
7 Mar 24
8-K
Entry into a Material Definitive Agreement
26 Dec 23
8-K
ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
13 Nov 23
8-K
ALX Oncology Announces Pricing of Public Offering
6 Oct 23
8-K
Results of Operations and Financial Condition
4 Oct 23
8-K
Other Events
4 Oct 23
8-K
Departure of Directors or Certain Officers
6 Sep 23
8-K
ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update
10 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
20 Jun 23
8-K
ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
11 May 23
Registration and prospectus
S-8
Registration of securities for employees
7 Mar 24
424B5
Prospectus supplement for primary offering
6 Oct 23
424B5
Prospectus supplement for primary offering
4 Oct 23
424B3
Prospectus supplement
8 Sep 23
S-3
Shelf registration
1 Sep 23
424B5
Prospectus supplement for primary offering
25 Aug 23
S-8
Registration of securities for employees
9 Mar 23
POS AM
Prospectus update (post-effective amendment)
27 May 22
S-3/A
Shelf registration (amended)
13 May 22
S-3
Shelf registration
25 Mar 22
Proxies
DEF 14A
Definitive proxy
22 Apr 24
DEF 14A
Definitive proxy
24 Apr 23
DEF 14A
Definitive proxy
22 Apr 22
DEF 14A
Definitive proxy
29 Apr 21
Other
EFFECT
Notice of effectiveness
11 Sep 23
CORRESP
Correspondence with SEC
7 Sep 23
UPLOAD
Letter from SEC
6 Sep 23
EFFECT
Notice of effectiveness
1 Jun 22
EFFECT
Notice of effectiveness
26 May 22
CORRESP
Correspondence with SEC
24 May 22
UPLOAD
Letter from SEC
29 Mar 22
EFFECT
Notice of effectiveness
10 Dec 20
CORRESP
Correspondence with SEC
7 Dec 20
CORRESP
Correspondence with SEC
7 Dec 20
Ownership
4
Jaume Pons
18 Apr 24
144
Notice of proposed sale of securities
16 Apr 24
4
Jaume Pons
5 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
4
Jason Lettmann
18 Mar 24
4
Shelly Pinto
16 Feb 24
4
PETER S GARCIA
16 Feb 24
4
Sophia Randolph
16 Feb 24
4
Jaume Pons
16 Feb 24
4
Jason Lettmann
16 Feb 24